About Richard Staines
Posts by Richard Staines:
Japan approves two more COVID vaccines as fourth infection wave hits
Richard Staines
coronavirus, COVID-19, infectious diseases, vaccine
0 Comment
R&D/ Views & Analysis/ Views and analysis
Arecor heads for London Stock Exchange with drug reformulation strategy
Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy
Richard Staines
Allogene, CAR T, Gilead, Kite Pharma, non-Hodgkin lymphoma, Oncology
0 Comment
Under-pressure GSK sells stake in respiratory diseases partner Innoviva
Richard Staines
Elliott Management, GlaxoSmithKline, Innoviva, M&A
0 Comment
News/ News/ Sales and Marketing
Avenir opens office in London’s Bankside
Richard Staines
Avenir Global, Axon, Cherry, comms, Hanover, Medano
0 Comment
NICE rejects J&J’s prostate cancer drug Erleada in initial guidance
Richard Staines
Johnson & Johnson, market access, NICE, Prostate cancer
0 Comment
LAG-3 drugs take centre stage at ASCO, showing potential as next-gen immunotherapies
Richard Staines
Bristol-Myers Squibb, cancer, Merck & Co, metastatic melanoma
0 Comment